Document Detail

Response to incremental doses of dobutamine early after reperfusion is predictive of the degree of myocardial salvage in dogs with experimental acute myocardial infarction.
MedLine Citation:
PMID:  10841249     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: We sought to determine whether the inotropic response to dobutamine might be useful for estimating the extent of viable myocardium soon after reperfusion. BACKGROUND: Early identification of viable myocardium in the presence of severe left ventricular dysfunction after reperfusion is important for clinical decision making. METHODS: Nine open-chest dogs had left anterior descending coronary artery occlusion for 40 to 180 min, followed by gradual reperfusion. The systolic thickening response to incremental dobutamine doses was measured with ultrasonic crystals and regional flow by microspheres. RESULTS: Dogs were divided into two groups based on triphenyl tetralozium chloride infarct size (group 1: 9.3 +/- 3.0% risk area; group 2: 51.1 +/- 4.8%). In group 2 dogs with larger infarcts, regional flow during peak dobutamine was lower than it was in group 1 in endocardial (1.15 +/- 0.22 vs. 2.64 +/- 0.33 mL x min(-1) x g(-1)) and midwall (1.47 +/- 0.32 vs. 2.92 +/- 0.36 mL x min(-1) x g(-1)) layers, and endocardial flow in group 2 failed to increase from baseline (0.96 +/- 0.07 vs. 1.15 +/- 0.22 mL x min(-1) x g(-1)). Group 1 dogs demonstrated a dose dependent increase in systolic thickening with dobutamine versus a blunted response in group 2. The inotropic response to only 10 microg x kg(-1) x min(-1) of dobutamine was predictive of the degree of myocardial salvage. CONCLUSIONS: In the early postischemic stunning phase of reperfusion, the inotropic response to dobutamine is predictive of the degree of myocardial salvage and ultimate infarct size. The ability to distinguish between stunned versus necrotic myocardium early after reperfusion was most likely due to the presence of subendocardial flow reserve during dobutamine in dogs with predominantly salvaged myocardium.
K Takehana; M Ruiz; F D Petruzella; D D Watson; G A Beller; D K Glover
Related Documents :
15534059 - Reduced oxidative metabolic response in dysfunctional myocardium with preserved glucose...
14583899 - Dobutamine potentiates the peripheral chemoreflex in patients with congestive heart fai...
17336749 - Risk stratification using stress echocardiography: incremental prognostic value over hi...
11175029 - Multiplane transesophageal echocardiography with dobutamine in patients with biventricu...
19914129 - The combined pharmacological stress echocardiography protocol for predicting improvemen...
2839569 - Effects of dopamine on left ventricular afterload and contractile state in heart failur...
3288679 - Doppler echocardiography for the diagnosis of acute cardiac allograft rejection.
2312989 - Long-term follow-up of patients with silent ischemia during exercise radionuclide angio...
17089239 - Use of coronary calcium score in the assessment of atherosclerotic lesions in coronary ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of the American College of Cardiology     Volume:  35     ISSN:  0735-1097     ISO Abbreviation:  J. Am. Coll. Cardiol.     Publication Date:  2000 Jun 
Date Detail:
Created Date:  2000-06-27     Completed Date:  2000-06-27     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8301365     Medline TA:  J Am Coll Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1960-8     Citation Subset:  AIM; IM    
Department of Medicine, University of Virginia Health System, Charlottesville 22908, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cardiotonic Agents / administration & dosage*
Dobutamine / administration & dosage*
Dose-Response Relationship, Drug
Myocardial Infarction / drug therapy*,  pathology,  physiopathology,  therapy
Myocardial Reperfusion
Predictive Value of Tests
Regional Blood Flow
Time Factors
Reg. No./Substance:
0/Cardiotonic Agents; 34368-04-2/Dobutamine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Determinants of forward pulmonary vein flow: an open pericardium pig model.
Next Document:  Local paclitaxel delivery for the prevention of restenosis: biological effects and efficacy in vivo.